Investor Alert

Cerecor Inc.



After Hours

 --Quotes are delayed by 20 min

Jul 23, 2021, 7:59 p.m.





+0.11 +3.86%


Volume 16,298

Quotes are delayed by 20 min


Previous close

$ 2.90

$ 2.85


-0.05 -1.72%

Day low

Day high




52 week low

52 week high




James A. Harrell

Presently, James A. Harrell holds the position of Chief Commercial Officer of Cerecor, Inc. He is also Owner & Principal at Nsci Group, Inc.

In his past career he held the position of Vice President-Marketing of Medimmune, Inc. and VP & General Manager-Specialty Pharmaceuticals at Covidien Ltd.

James A. Harrell received an undergraduate degree from Samford University.


Date Shares Transaction Value
06/10/2021 7,493   Acquisition at $2.28 per share. 17,084
12/10/2020 171   Acquisition at $2.28 per share. 389
06/10/2020 6,391   Acquisition at $2.28 per share. 14,571
06/09/2020 10,000   Acquisition at $2.5 per share. 25,000
12/10/2019 3,064   Acquisition at $2.85 per share. 8,732
12/10/2018 4,156   Acquisition at $2.85 per share. 11,844

Officers and Executives

Mr. Michael F. Cola
Chairman & Chief Executive Officer
Mr. Schond L. Greenway
Chief Financial Officer & Treasurer
Dr. Garry Arthur Neil
Chief Scientific Officer
Dr. H. Jeffrey Wilkins
Chief Medical Officer
Dr. Younok Dumortier Shin
Chief Technology Officer
Dr. Lisa Hegg
Vice President-Research & Development Programs
Mr. James A. Harrell
Chief Commercial Officer
Mr. Joseph M. Miller
Mr. Christopher Sullivan
Chief Accounting Officer
Ms. Colleen Matkowski
Vice President-Global Regulatory Affairs
Dr. Suzanne Louise Bruhn
Lead Independent Director
Dr. Gilla Kaplan
Independent Director
Dr. Gunnar Magnus Modee Persson
Independent Director
Mr. Phillip P. Gutry
Independent Director
Mr. Steven Joseph Boyd
Independent Director
Link to MarketWatch's Slice.